Nuvalent:计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据

美股速递
Nov 17, 2025

Nuvalent:计划在预 NDA 会议上与 FDA 讨论 TKI 预治疗 ALK 阳性 NSCLC 人群的关键数据

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10